WHA68.18 - Global Strategy and Plan of Action on Public Health, Innovation and Intellectual Property. WHA Resolution; Sixty-eighth World Health Assembly, 2015
(2015; 3 pages) [Arabic] [Chinese] [French] [Russian] [Spanish]

Abrégé

REQUESTS the Director-General:

  1. to initiate, in line with the WHO evaluation policy and guided by the WHO evaluation practice handbook, the comprehensive evaluation of the implementation of the global strategy and plan of action on public health, innovation and intellectual property in June 2015, pursuant to the terms of reference specified in document A68/35; to present the inception report and comments of the evaluation management group to the Executive Board for consideration at its 138th session in January 2016; and to submit the final comprehensive evaluation report to the Seventieth World Health Assembly for consideration in 2017, through the Executive Board;
  2. to convene an ad hoc evaluation management group to assist the comprehensive evaluation composed of six independent external subject matter experts, and two evaluation experts from the United Nations Evaluation Group;
  3. to select the six independent external subject matter experts in line with guidelines for selection of members for ad hoc evaluation management groups included in the WHO evaluation practice handbook, including through consultation with the Regional Directors;
  4. to establish a panel of 18 experts respecting gender balance, equal regional representation, and diversity of technical competence and expertise to conduct the overall programme review, with a broad and balanced mix of expertise, practical experience and backgrounds covering the eight elements of the global strategy and plan of action on public health, innovation and intellectual property, and including experts from developed and developing countries;
  5. to invite Member States to nominate experts, including through the Regional Directors, for the roster beginning immediately following the 139th session of the Executive Board from which the Director-General will select the panel of 18 members for the overall programme review;
  6. to present the terms of reference of the overall programme review for approval by the Executive Board at its 140th session in January 2017, and to present the composition of the overall programme review panel for consideration by the bureau of the Executive Board in February 2017;
  7. to present the final report of the overall programme review of the global strategy and plan of action on public health, innovation and intellectual property, focusing on its achievements, remaining challenges and recommendations on the way forward to the Seventy-first World Health Assembly in 2018 through the 142nd session of the Executive Board.
 
Le Portail d'information - Médicaments essentiels et produits de santé a été conçu et est maintenu par l'ONG Human Info. Dernière mise à jour: le 1 décembre 2019